EMVOID 125MG/80MG CAP - mTatva Health-PIE

Contents

1 Overview
2 Usage
3 Frequently Asked Questions
4 Precautions for EMVOID 125MG/80MG CAP and its Constituents
5 Common Side-Effects
6 Rare Side-Effects
7 Disease Interactions
8 Technical Classification
9 Available Alternatives for EMVOID 125MG/80MG CAP
- 9.1 What are the commonly available Substitutes?
- 9.2 What are the other drugs with similar Ingredients?
10 Share this:
11 Like this:
12 Related Articles

Overview

EMVOID 125MG/80MG CAP is a Schedule H drug.

EMVOID 125MG/80MG CAP is composed of: APREPITANT (125.0 MG)

Aprepitant is used in adults and children to prevent nausea and vomiting caused by cancer chemotherapy. Aprepitant is also used (only in adults) to prevent nausea and vomiting that may be caused by surgery. Aprepitant blocks the actions of chemicals in the body that trigger nausea and vomiting

Usage

APREPITANT can address symptoms like: Nausea, Vomit

Frequently Asked Questions

Q: Is it safe on my liver?
A: Check with your Doctor first

Q: Is it safe on my kidney?
A: Check with your Doctor first

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Ask your doctor

Q: Can it be taken during pregnancy?
A: Considered as Generally Safe – not enough studies to prove risk

Q: Is it safe to take for someone breastfeeding?
A: Not Safe

Precautions for EMVOID 125MG/80MG CAP and its Constituents

Caution should be exercised in patients with history of nausea or vomiting, liver disease, any allergy, who are taking other medications, during pregnancy and breastfeeding. Do not take aprepitant if you are on following medications, astemizole, cisapride, pimozide, or terfenadine. It may cause dizziness, do not drive a car or operate machinery while taking this medication. Avoid alcohol consumption.

Common Side-Effects

APREPITANT : Abdomen Pain, Loss Of Appetite, Cough, Dizziness, Fatigue (tiredness), Constipation

Rare Side-Effects

APREPITANT : Skin Rash, Body Itching, Dizziness, Face Swelling, Difficulty Breathing

Disease Interactions

APREPITANT can interfere with: Acute Liver Failure

Technical Classification

APREPITANT is categorized as: MISCELLANEOUS ANTIEMETICS / ANTIEMETIC/ANTIVERTIGO AGENTS / CENTRAL NERVOUS SYSTEM AGENTS

Available Alternatives for EMVOID 125MG/80MG CAP

What are the commonly available Substitutes?

APRECAP 125MG CAP	INR 1215 for 3 CAPSULES	APREPITANT 125.0 MG
APREPEP 125MG CAP	INR 1049 for 3 CAPSULES	APREPITANT 125.0 MG
APRISET KIT	INR 1457.13 for 3 CAPSULES	APREPITANT 125.0 MG
APRISTAR 125MG/80MG CAP	INR 1300 for 3 CAPSULES	APREPITANT 125.0 MG
EMPOV 125MG CAP	INR 1238.1 for 3 CAPSULES	APREPITANT 125.0 MG
EMVOID 125MG/80MG CAP	INR 852.5 for 3 CAPSULES	APREPITANT 125.0 MG

What are the other drugs with similar Ingredients?

APRECAP 150MG INJ	INR 2309.82 for 1 INJECTION	APREPITANT 150.0 MG
APRELIEF KIT	INR 1270.01 for 1 CAPSULE	APREPITANT
APREPIT KIT	INR 1000 for 1 KIT	APREPITANT
APREPITANT		APREPITANT
APRISET 150MG INJ	INR 2314.28 for 10 ML INJECTION	APREPITANT 150.0 MG